INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them
Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.
-
How Do Site Payments Impact Clinical Trial Sustainability?
Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,
-
Stay Audit-Ready: Practical Compliance Insights For Research Sites
Gain an auditors insight into common compliance gaps and learn practical ways to strengthen audit readiness in sIRB studies.
-
Targeted Protein Degraders: Transforming Oral Therapeutics
CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
-
Developing Community-Based And Trial-Naïve Sites: The Real ROI9/9/2025
Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.
-
Why Should Site Agility Be Your Next Competitive Advantage?1/26/2026
Maximize your trial agility by replacing slow, linear start-ups with parallel workflows and rapid SLAs. Partnering with agile sites secures a commercial edge and predictable timelines.
-
Navigating Participant Payment Challenges: A New Approach For Sponsors And Sites11/4/2024
As trials grow more sophisticated and operate on a larger, global scale, understanding the nuances of participant payment management has become essential for sponsors and sites alike.
-
Taking A Concierge Approach To Modern Pharma Meetings12/10/2025
Pharma meetings run smoother when they reflect real site needs. This article breaks down how travel, timing, venue, and training choices strengthen engagement from the start.
-
The Hidden Financial Causes Of Patient Transportation Breakdowns In Clinical Trials6/15/2026
Transport issues in trials often stem from fragmented financial workflows. Integrating payments with travel coordination reduces delays and supports reliable visits.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
In the face of the COVID-19 pandemic, biopharmaceutical companies had to react quickly to develop and implement what were frequently large scale crisis response initiatives. Read how now is the time to assess the changes that were implemented and refine business continuity plans to ensure regulatory compliance, patient safety, and organizational preparedness now and into the future.
-
Worldwide Flex provides flexible, scalable solutions and services to enhance our clients’ outsourcing needs. We are a specialized provider of multi-therapeutic functional solutions delivered by our experts.
-
Accelerator™ Drug Development provides a strategic, end-to-end partnership model that helps sponsors optimize resources, overcome development challenges, and advance promising therapies.
-
Our turnkey operational infrastructure empowers sponsors and partners to execute trials more efficiently — reducing costs, accelerating timelines, and consistently delivering high-quality data.
-
Accelerate your cell or gene therapeutic to market with tailored clinical and regulatory strategies and expert insights.